Free Trial

ADMA Biologics (ADMA) Earnings Date, Estimates & Call Transcripts

ADMA Biologics logo
$10.25 -0.06 (-0.58%)
Closing price 04:00 PM Eastern
Extended Trading
$10.30 +0.05 (+0.47%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ADMA Biologics Earnings Summary

ADMA Biologics released Q4 2025 earnings on February 25, 2026, reporting an EPS of $0.20, which met the consensus estimate of $0.20. Quarterly revenue rose 18.4% year-over-year to $139.16 million, below analysts' expectations of $139.80 million. With a trailing EPS of $0.60 and a P/E Ratio of 17.08, ADMA Biologics' earnings are expected to grow 44.09% next year, from $0.93 to $1.34 per share.

Upcoming
Earnings Date
May. 6After Market ClosesEstimated
Consensus EPS
(Feb. 25)
$0.20
Actual EPS
(Feb. 25)
$0.20
Actual Revenue
(Feb. 25)
$139.16M

Q4 2025 Earnings Resources

ADMA Upcoming Earnings

ADMA Biologics' Q1 2026 earnings is estimated for Wednesday, May 6, 2026, based on past reporting schedules, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get ADMA Biologics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ADMA Biologics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ADMA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADMA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

ADMA Biologics Analyst EPS Estimates

Current Year EPS Consensus Estimate
$0.93 EPS
Next Year EPS Consensus Estimate
$1.34 EPS

ADMA Biologics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2026
(Estimated)
-------
2/25/2026Q4 2025$0.20$0.20-$0.20$139.80M$139.16M
11/5/2025Q3 2025$0.16$0.16-$0.15$131.20M$134.22M
8/6/2025Q2 2025$0.14$0.15+$0.01$0.14$121.77M$121.98M
5/7/2025Q1 2025$0.16$0.14 -$0.02$0.11$116.40M$114.80M
11/7/2024Q3 2024$0.13$0.15+$0.02$0.15$107.25M$119.84M
8/8/2024Q2 2024$0.08$0.13+$0.05$0.13$86.44M$107.20M
5/9/2024Q1 2024$0.05$0.08+$0.03$0.08$77.28M$81.90M

Data powered by Fiscal.ai.

ADMA Biologics Earnings - Frequently Asked Questions

ADMA Biologics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 6th, 2026 based off last year's report dates. Learn more on ADMA's earnings history.

ADMA Biologics issued an update on its FY 2026 earnings guidance on Tuesday, March, 3rd. The company issued revenue guidance of $635.0 million-, compared to the consensus revenue estimate of $635.0 million.

In the previous quarter, ADMA Biologics (NASDAQ:ADMA) reported $0.20 earnings per share (EPS) to hit the analysts' consensus estimate of $0.20. Learn more on analysts' earnings estimate vs. ADMA's actual earnings.

The conference call for ADMA Biologics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for ADMA Biologics' latest earnings report can be read online.
Read Transcript

ADMA Biologics (NASDAQ:ADMA) has a recorded annual revenue of $510.17 million.

ADMA Biologics (NASDAQ:ADMA) has a recorded net income of $146.93 million. ADMA has generated $0.60 earnings per share over the last four quarters.

ADMA Biologics (NASDAQ:ADMA) has a trailing price-to-earnings ratio of 17.08 and a forward price-to-earnings ratio of 11.02.

ADMA Biologics' earnings are expected to grow from $0.93 per share to $1.34 per share in the next year, which is a 44.09% increase.


This page (NASDAQ:ADMA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners